Public Profile

Mingqi Pharmaceutical

Mingqi Pharmaceutical, a prominent player in the pharmaceutical industry, is headquartered in China (CN) and operates extensively across various regions. Founded in the early 2000s, the company has established itself as a leader in the development and manufacturing of innovative pharmaceutical products, particularly in the fields of oncology and cardiovascular health. Mingqi Pharmaceutical is renowned for its commitment to quality and research-driven solutions, offering a diverse portfolio that includes both generic and proprietary medications. The company’s unique approach to drug formulation and delivery systems sets it apart in a competitive market. With a strong emphasis on sustainability and patient-centric solutions, Mingqi has achieved significant milestones, including numerous regulatory approvals and partnerships with global healthcare providers, solidifying its position as a trusted name in the pharmaceutical landscape.

DitchCarbon Score

How does Mingqi Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

0

Industry Average

Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

9

Industry Benchmark

Mingqi Pharmaceutical's score of 0 is higher than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.

69%

Mingqi Pharmaceutical's reported carbon emissions

Mingqi Pharmaceutical, headquartered in CN, currently does not have available data on its carbon emissions, as no specific emissions figures have been reported. Consequently, there are no documented reduction targets or climate commitments outlined by the company. In the absence of concrete emissions data, it is essential to note that many pharmaceutical companies are increasingly focusing on sustainability and climate action, often setting ambitious targets to reduce their carbon footprint. However, without specific information from Mingqi Pharmaceutical, it is unclear what initiatives or commitments they may have in place regarding carbon emissions and climate change.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Mingqi Pharmaceutical's primary industry is Other business services (74), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Mingqi Pharmaceutical is headquartered in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Mingqi Pharmaceutical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Business Services

Callidus Solutions Ltd

US
Business Services
Updated 3 days ago

SM Consulting

KR
Business Services
Updated 11 days ago

Qube Holdings

AU
Business Services
Updated 3 days ago

Zest Business Group

GB
Business Services
Updated 11 days ago

Versacold

CA
Business Services
Updated 3 days ago

Feld Leasing Co. Inc.

US
Business Services
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers